Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice
Jacob E. Friedman(University of Oklahoma Health Sciences Center), Karen R. Jonscher(Unknown), Julie A. Reisz(University of Colorado Anschutz Medical Campus), David J. Orlicky(University of Colorado Anschutz Medical Campus), Becky A. de la Houssaye(University of Colorado Cancer Center), Karim C. El Kasmi(Children's Hospital Colorado), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Charles E. Robertson(Duke University), Xiaoxin X. Wang(Beijing Obstetrics and Gynecology Hospital), Evgenia Dobrinskikh(University of Colorado Anschutz Medical Campus), Aimee L. Anderson(Children's Hospital Colorado), Eric O. Potma(University of California, Irvine), Daniel N. Frank(University of Colorado Anschutz Medical Campus), Linda K. Johnson, Moshe Levi(University of Colorado Anschutz Medical Campus), Alexander Fast(University of California, Irvine), Rachel C. Janssen(University of Colorado Anschutz Medical Campus), Taylor K. Soderborg, Alba Alfonso‐García(University of California, Irvine)
Cited by 59
Related Papers
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
|Science|2013|2k
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
|Diabetes Care|2007|790
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556